Hamilton Lane Incorporated (HLNE) Stock Price & How to Invest

Hamilton Lane Incorporated is a private-markets investment and advisory firm founded in 1991 and listed on Nasdaq since 2017, with roughly 800 professionals across North America, Europe, Asia Pacific and the Middle East. It sits between institutional investors and private-markets fund managers rather than running buyouts itself. The business has three revenue shapes. Customized separate accounts are discretionary mandates run for pensions, insurers and sovereign funds. Specialized funds are commingled vehicles covering secondaries, co-investment and direct equity, private credit, infrastructure and impact, and this is where fee rates are highest. Advisory and technology work (reporting, monitoring, portfolio construction and the Cobalt analytics platform) covers a far larger asset base at much thinner economics. As of June 30, 2026 the firm reported roughly $1.1 trillion in assets under management and supervision, split between about $146.3 billion of discretionary assets and about $914.1 billion of non-discretionary advisory assets.

The number that actually drives revenue is fee-earning AUM, which was about $83.7 billion at the end of the June 2026 quarter, up roughly 12% year over year, with specialized-fund fee-earning AUM at about $42.6 billion (up about 25%) at a blended rate near 69 basis points. Quarterly revenue was about $275 million and fee-related earnings about $124 million, up roughly 49% year over year at a margin near 53%. The evergreen platform, the semi-liquid vehicles sold through wirehouses, RIAs and private banks, passed $19 billion in AUM with about $640 million of net inflows in the quarter, and is the growth engine management points at most often. The complication is that in April 2026 a short-seller report from Hunterbrook questioned how fee-related earnings are presented, specifically the inclusion of incentive revenue tied to unrealized marks and the exclusion of stock-based compensation, and several plaintiff firms opened investigations afterward. The stock's roughly $6.99 billion market capitalization against about $858 million of trailing revenue is best read as the market pricing both the growth and that dispute at the same time.

The accounting dispute is the first-order risk: the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. Second, incentive fees and carried interest depend on exits, so a prolonged slow market for private-markets realizations can flatten the most profitable revenue line for several quarters. Third, fundraising is episodic, and a specialized fund that raises below its predecessor shows up directly in fee-earning AUM. Fourth, the evergreen push depends on distribution partners who can reallocate shelf space to Blackstone, Apollo, Ares or Blue Owl at any time, and semi-liquid funds carry redemption risk if private marks fall. Finally, the roughly $914 billion advisory book is large but low-fee, and clients that build internal teams or renegotiate retainers can shrink it without any change in market conditions.

7 analysts publish price targets on HLNE, averaging $133.57 against a $104.24 price as of August 2026, or +28.1%. The published targets run from $105.00 to $182.00, a moderate spread, and the ratings split 6 buy, 1 hold, 0 sell. Over the last six months there have been 4 raises and 8 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full HLNE forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Hamilton Lane Incorporated. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Evergreen and private-wealth distribution. The evergreen platform passed $19 billion in AUM with roughly $640 million of net inflows in the June 2026 quarter, and it carries higher fee rates than the institutional separate-account book. The most optimistic published target, $182.00, assumes this works close to its best case.

The case against. The accounting dispute is the first-order risk: the April 2026 Hunterbrook report alleged that day-one markups on secondary purchases and incentive accruals on unrealized gains flatter fee-related earnings, plaintiff firms including Johnson Fistel opened investigations, and a change in presentation or a regulatory inquiry would hit sentiment even without changing cash flows. The most pessimistic target, $105.00, is roughly what HLNE is worth if this bites instead.

Read the full bull and bear case on HLNE, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Hamilton Lane Incorporated's investor relations page or your broker.

• Revenue (TTM): ~$858 million (June 2026 quarter ~$275 million)
• Market capitalization: ~$6.99 billion at a share price of ~$104
• Price to trailing revenue: ~8x
• Fee-earning AUM: ~$83.7 billion, up ~12% year over year
• Assets under management and supervision: ~$1.1 trillion (~$146.3 billion discretionary, ~$914.1 billion advisory)
• Dividend: $0.60 quarterly, ~$2.40 targeted for fiscal 2027 (~2.3% yield), up ~11%

Hamilton Lane runs on an April-to-March fiscal year, so the quarter ended June 30, 2026 is its fiscal 2027 first quarter. Fee-related earnings of about $124 million on roughly $275 million of quarterly revenue is the number bulls anchor on and the number the short case attacks, because it includes incentive revenue linked to unrealized marks and excludes stock-based compensation. Comparing the multiple to Blackstone or Ares also requires adjusting for the Up-C structure, where the listed Class A shares represent only a portion of the economics of the underlying operating partnership.

Other names that sit close to HLNE: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get HLNE exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so HLNE sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where HLNE fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Hamilton Lane is a fee-driven private-markets allocator with a fast-growing evergreen wealth franchise and a rising dividend, priced at a multiple that reflects an unresolved dispute over whether its reported fee-related earnings are as clean as the headline growth suggests.

Whether HLNE is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is HLNE a buy or a sell?, and where the stock could go from here in the HLNE stock forecast.

For income investors, whether HLNE pays a dividend and how the payout looks is covered in does HLNE pay a dividend? And to weigh HLNE against a peer, read the full side-by-side comparisons: HLNE vs STEP and HLNE vs GCMG.